Introduction
A great variety of therapeutic genes have shown promise in the treatment of human genetic diseases, but the lack of optimal delivery systems is still an important limitation. 1 Viral vectors that are known to have high transfection efficiency have been widely used in restoration of the gene in deficient cells. 2 However, the major disadvantages of these vectors are their immunogenicity, size limitation and safety. 3 Non-viral vectors have been increasingly proposed as alternatives to viral vectors and many of them are being developed based upon the construction of artificial virus-like particles. 4 Cationic polymers complexed with the plasmid DNA meet some of the requirements of virus-like vectors and they are being investigated extensively. 5 Cationic polymers such as polyethyleneimine (PEI), poly-L-lysine (PLL), poly-dimethyl-ammonio ethyl methacrylate (DMAEMC) and poly-trimethylammonio ethyl methacrylate (TMAEM) are known to mask the negative charges on the DNA and reduce the size of larger genes by condensing them into smaller structures by electrostatic forces, thereby facilitating cell entry. [6] [7] [8] [9] In spite of their efficient gene transfer in vitro, polycation/DNA complexes undergo rapid clearance from the plasma, which decreases their potential for the specific target in Correspondence vivo. 10 In addition, interactions of DNA complexes and plasma proteins can be the major obstacle for their in vivo efficiency. 11 Therefore, several cationic polymers have been used in combination with hydrophilic non-ionic polymers to form stable DNA/polymer complexes (ie PLL-dextran, PLL-PEG, pTMAEM-HPMA, pDMAEM-HPMA, etc). 8, 9, [12] [13] [14] These copolymers are known to improve solubility and stability of the DNA complexes. Furthermore, the hydrophilic segments in the copolymer produce a steric barrier to interaction with nucleases and phagocytes, thereby prolonging plasma circulation times. [12] [13] [14] In a recent study, it was shown that the block and graft copolymers of N-(2-hydroxylpropyl methacrylamide) (HPMA) with TMAEM improved solubility of DNA complexes and reduced aggregation of the DNA complexes due to the hydrophilic monomer in the copolymer. 9 In this study, we have synthesized a cationic hydrophilic homopolymer of N-trimethylammonium ethyl methacrylate chloride (pTMAEM) and its copolymers with neutral hydrophilic 1-vinyl-2-pyrrolidinone (VP) and hydrophobic methylmethacrylate (MMA), and examined their ability to interact with the negatively charged DNA. The physiochemical properties of complexes between the polymers and the DNA were determined by several methods, including zeta potential, particle size and fluorescence quenching. The biological behaviors, such as cytotoxicity and transfection efficiency, of the complexes were also investigated. TMAEM  100  130 000  TMAEM-VP15  85/15  154 000  TMAEM-VP30  70/30  140 000  TMAEM-MMA15  85/15  320 000  TMAEM-MMA30 70/30 234 000
Results and discussion
Physicochemical characteristics of polymer/DNA complexes The ability of pTMAEM and its copolymers (pTMAEM-VP and pTMAEM-MMA) ( Table 1) to interact with DNA was evaluated by several methods include gel electrophoresis, fluorescein quenching, dynamic light scattering and zeta potential. All the polymers tested were able to slow down or inhibit plasmid migration in agarose gel, depending on polymer type and polymer/DNA weight ratios ( Figure 1 ). At low weight ratios, DNA remained in the wells during electrophoresis and the intensity of fluorescence of the bands was less than free DNA, suggesting that cationic polymers interacted electrostatically with the DNA and formed compact particles ( Figure 1 ). Complete inhibition of DNA migration occurred above 0.5 (w/w) of pTMAEM/DNA and the incorporation of neutral comonomers (VP and MMA) increased the weight ratio to 2, probably because positive charges on the surface were slightly shielded by the presence of the VP or MMA as a result of their association with DNA and were weaker than the homopolymer (Figure 1 ). Another method for monitoring changes in DNA interaction with polycation is to determine the ability of an intercalating agent to bind to the DNA. 15 Addition of increasing amounts of pTMAEM to EtBr/DNA complexes decreased the fluorescence intensity due to intercalated dye ( Figure 2 ). The maximum quenching was first achieved near the neutralization point (between the weight ratios 0.5 and 1), where the positive charges of pTMAEM balanced the negative phosphate charges on the DNA. The residual fluorescence at this point was 15 ± 8.7%. The copolymers of pTMAEM with VP or MMA also induced a reduction of fluorescence, but the starting copolymer/DNA weight ratio was higher (>1 w/w) than homopolymer (0.5 w/w) ( Figure 2 ). The residual fluorescence of copolymer/DNA complexes increased with increasing comonomer content and reached the maximum value of 27 ± 6.4% showing that copolymers bound less tightly to the DNA. As previously explained this may be due to steric hindrance that was provided by the neutral blocks to the polyelectrolyte interaction.
Overall results indicate that EtBr is removed from DNA either as a result of DNA-polymer condensation or polymer attachment to the DNA hampered EtBr access.
These observations were correlated with the DNase protection assay that was conducted to ascertain binding of the cationic polymers to the DNA. The experiment conditions were optimized in our previous studies. 16 Results revealed that free DNA was rapidly degraded by DNase within a short time period whereas DNA in (co)polymer/DNA complexes was partially or completely resistant to DNase depending upon (co)polymer/DNA weight ratios ( Figure 3 ). Increasing (co)polymer/DNA weight ratios decreased the degradation of DNA and total elimination of the smear was observed at weight ratios of 1 and 2 with pTMAEM and copolymers, respectively. Incorporation of VP or MMA at the high content (30%) did not hamper the ability of copolymers to protect DNA from nuclease degradation suggesting that DNA is also efficiently condensed by the copolymers.
The size of the complexes was analyzed using laser light scattering to determine if results from previous experiments were linked to the size of the polymer/DNA complexes. All the samples were prepared either in water or hepes buffer, as explained previously. An effective diameter of uncomplexed DNA could not be determined due to the elongated nature of the DNA. 15 The particle size of the pTMAEM/DNA was found to be 550 ± 178 nm at low weight ratios (Ͻ0.5) and it became smaller (195 ± 38.8 nm) with increasing polymer/DNA ratios ( Figure  4 ). The results indicate that at high polymer/DNA ratios, positive charges were enough to completely cover the negatively charged phosphate groups of the plasmid and formed small particles (~195 nm). It is clear that pTMAEM was able to effectively condense the DNA since the average hydrodynamic diameter of the plasmid is~400 nm. In a previous study, the formation of large aggregates at low pDMAEM was ascribed to cross linking of plasmid by the polymer. 17 The size of copolymer/DNA complexes as a function Gene Therapy of copolymer ratio shows the same trend as that of the homopolymer/DNA complexes ( Figure 4 ). As observed for pTMAEM/DNA, the condensing properties of the copolymers improved with increasing polymer/DNA weight ratios. For example, the particle size of pTMAEM-VP30/DNA was 750 ± 108 nm at weight ratio of 0.25 and it was reduced to 268 ± 41 nm at 2 w/w. We did not observe significant differences in the size between the copolymers at same monomer content and polymer/DNA weight ratios (Figure 4) . Overall, the particle size of TMAEM/DNA complexes (550-195 nm) was smaller than copolymer/DNA complexes at all polymer/DNA ratios (1200-300 nm) tested. The variation in particle size may be due in part to the number of DNA molecules incorporated per complex or low positive charges in copolymers that may have led to weak electrostatic interactions between the copolymer and the DNA thereby caused the formation of aggregates.
It has been reported in the literature that cationic polymers mediate aggregation of their DNA complexes under physiological buffer conditions. 15 In addition, the aggregation of polycation/DNA complexes plays a significant role in nonspecific uptake of the complexes in vivo, but it can be reduced by introduction of an inert hydrophilic polymer. 12 Here, we have found that pTMAEM and pTMAEM-MMA/DNA complexes incubated in the presence of salt for 45 min produced slightly larger particles than those formed in water (P > 0.05) (data not shown). This discrepancy may reflect differences in the incubation time that was relatively short in this study. In addition, incorporation of hydrophilic monomer (VP) enhanced the stability of copolymer/DNA particles in hepes buffer, probably reflecting greater hydrophilicity due to the monomer (data not shown). It has also been shown that high content of N-2-hydroxypropyl methylacrylamide (HPMA) was necessary to form stable pTMAEM-HPMA/DNA particles in 0.15 M NaCl. 9 The aggregation of colloidal particles can also be controlled by the charge on the surface of the particles that was assessed by Zetameter. Polymer/DNA complexes at weight ratio of 1 and below have negative zeta potential values (ϽϪ30 ± 10 mV) and larger particle size probably due to the incomplete formation of particles under these conditions. The crossover from negative to positive zeta potential occurred at or very near neutral charge ratio (0.5 w/w ratio) suggesting that one primary amine interacts per phosphate group of the DNA. Increasing polymer/DNA ratio increased zeta potential value (>+28 mV) ( Figure 5 ) and the zeta potential remained constant above 1 polymer/DNA weight ratio, most likely due to the excess amount of polymer that existed in the complexes. Cationic pTMAEM possess high binding affinity to DNA and as expected a positive zeta potential (5 ± 4.5 mV) was observed at a weight ratio of 0.5 and remained positive above this ratio ( Figure 5 ). The plateau value of pTMAEM/DNA was 28 ± 12.7 mV and it was similar with copolymer/DNA complexes containing 15% VP or MMA (P > 0.05) ( Figure 5 ). In contrast, copolymers at high comonomer content (30%) decreased the plateau value of zeta potential from +28 mV to +21 mV (P > 0.05) and the weight ratio at which this value was reached increased from 1 to 4. The slight fall in zeta potential observed here may represent shielding of the surface charge of the copolymer/DNA complexes. These observations are correlated with particle size results. 
Biological characteristics of polymer/DNA complexes
Transfection and cytotoxicity studies were carried out in COS-7 cells as explained in Materials and methods. To determine optimum transfection time, pTMAEM/DNA complexes were selected at two different polymer/DNA weight ratios (2 and 8 w/w). The cells were treated with pTMAEM/DNA complexes for 30 min, 1 h, 2 h 4 h, 8 h, 16 h, 24 h and 48 h as explained in Materials and methods. The maximum transfection efficiency was found after 1 h when the cells were transfected with pTMAEM/DNA at high polymer/DNA ratio (8 w/w), whereas transfection efficiency increased with time and reached the maximum at low ratio (2 w/w). The differences in transfection efficiency can be explained by the toxicity of the pTMAEM homopolymer at high polymer/DNA ratio (8 w/w) in COS cells. Based on these results, the cells were treated with the transfection medium for 4 h throughout the experiments. In addition, in in vitro cationic polymer-mediated gene expression studies, high gene expression usually correlated with an excess of cationic charges in the absence of serum. Therefore, transfection and cytotoxicity studies were conducted in the presence of serum FBS (10%). Lipofectamine was used as a control throughout the experiments.
All the polymer/DNA complexes yielded a higher transfection efficiency compared with plasmid alone (data not shown). The relative transfection efficiency of the complexes as a function of the weight ratio is shown in Figure 6 . Transfection efficiency of pTMAEM reached the optimal value (655 mU/mg protein) at a weight ratio of 0.5. Low transfection efficiency at low ratio could be ascribed to less particle uptake by the cells due to larger particle size and high negative zeta potential (Figure 3 ). Transfection efficiency of pTMAEM/DNA reduced from 655 to 526 mU/ mg protein by increasing weight ratio (> 2) at which the complexes possess high positive charges that are not neutralized under these conditions and thereby increased cytotoxicity (48%) (Figures 6 and 7) . This could also be explained by nonspecific interactions of excess cationic charges with negatively charged serum components. We thought that changing monomer ratio of the copolymers (pTMAEM-VP and pTMEAM-MMA) could alter the physicochemical, as well as biological characteristics of polymer/DNA complexes. Interestingly, at both monomer contents (15 and 30%), the complexes of DNA with VP showed similar transfection ability as the homopolymer/DNA complexes (P > 0.05), except that the weight ratio at which maximum transfection efficiency (652 mU/mg protein) was reached increased to 1 with increasing monomer content in the copolymers ( Figure 6 ). In addition, cytotoxicity of these complexes was less than pTMAEM ( Figure 7 ) and indicates that comonomer masked the cytotoxicity of the TMAEM. These results can be explained by combination of condensation of DNA and protection of complex by hydrophilic segment in the copolymer.
On the other hand, incorporation of both low and high amounts (15 and 30%) of MMA in the copolymers reduced the transfection efficiency and increased the cytotoxicity as compared with pTMAEM ( Figures 6 and  7) . Similar results were observed in another study where the hydrophobic character of pDMAEM was increased by incorporating MMA, which enhanced membrane destabilizing properties of pDMAEM. 17 In conclusion, physicochemical and biological characteristics of (co)polymer/DNA complexes were affected by the presence of the monomer, whereas changes in monomer ratio had minimum effect on these characteristics. Although, all the polymers showed ability to transfect the COS-7 cells, copolymers of TMAEM with VP showed better physicochemical and biological characteristics compared with other (co)polymers. Incorporation of MMA at both monomer ratios had no beneficial effect. However, further studies are required to investigate whether or not the proposed system could be a good candidate for in vivo non-viral gene delivery systems.
Materials and methods

Materials
Plasmid DNA (pSV-␤-galactosidase) (6820 bp) and lysis buffer were obtained from Promega (Madison, WI, USA). Qiagen Ultra Pure column and endotoxin-free buffers were purchased from Qiagen (Valencia, CA, USA). Monkey kidney epithelial cell line (COS-7) was obtained from American Type Culture Collection (ATCC) (Rockville, MD, USA). Minimum essential medium (MEM), Dulbecco's modified Eagle medium (DMEM), fetal bovine serum, lipofectamine and antibiotics were purchased from Gibco BRL (Grand Island, NY, USA). The monomers, trimethylammoniumethylmethacrylate (TMAEMC, MW = 206.5 g/mole), N-vinyl-pyrolidone (VP, MW = 99) and methylmethacrylate (MMA, MW = 100.1) were obtained from Rohmtech (Piscataway, NJ, USA). Initiator 2,2'-azobisisobutyronitrile (AIBN) was purchased from Wako Pure Chemical Industries (Osaka, Japan). Hepes, ethanol, acetonitrile, tetrahydrofuran, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) were obtained from Sigma Chemical (St Louis, MO, USA). Polystyrene standards were purchased from Polyscience (Warrington, PA, USA). All other chemicals were of analytical grade.
Preparation of plasmid DNA
The plasmid pSV-␤-Gal was amplified in E. coli (DH-5␣), extracted using alkaline lysis method and purified by a Qiagen EndoFree Ultra Pure column. 16 The DNA was precipitated in 100% ethanol and rehydrated in sterile Tris-EDTA buffer. Plasmid identity and purity were confirmed by restriction endonuclease digestion (HindIII and EcoRI) in 1.0% agarose gel and a UV-1201 (Schimadzu, Kyoto, Japan) spectrophotometer at 260/280 nm. Endotoxin level was determined using an endotoxin assay kit (Biowhittaker) according to the manufacturer's protocol.
Polymer synthesis and characterizations TMAEM homopolymer and its copolymers with MMA and VP at 85/15 and 70/30 TMAEM/comonomer weight ratios were synthesized by free radical chain reaction polymerization as described in previous studies. 18 Briefly, appropriate amounts of monomers were dissolved in either water or ethanol. The polymerization reactions were initiated by adding 0.5% w/w of 2,2'-Azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride and the reactions were carried out at 63°C for 24 h. Polymers were isolated by membrane dialysis against deionized water at room temperature using a Spectra/Por Cellulose Ester membrane and the final products were collected by lyophilization.
The weight-average molecular weight (MW) and numGene Therapy ber-average molecular weight (MN) of the copolymers was determined by gel permeation chromatography (GPC). The measurements were carried out with C0001-01N TSK-Gel column equipped with a refractive index detector RID-6A. The flow rate was 1 ml/min and samples were eluted using an aqueous solution or organic solution of ethanol:acetonitrile:tetrahydrofuran (3:2:4). Molecular weights were calculated using polystyrene standards of known molecular weights.
DNA-polymer complexation
Polymers were dissolved in hepes buffer solution (5 mM Hepes, 150 mM NaCl pH 7.3) unless otherwise stated and aliquots of these solutions were added to plasmid in the same medium to obtain 0.25, 0.5, 1, 2, 4 and 8 polymer/DNA weight ratios. The mixtures were then briefly vortexed and incubated at room temperature for 45 min. Polymer/DNA complexes were analyzed by agarose gel electrophoresis as explained previously. 16 The complexes were freshly prepared for each experiment.
Fluorescein quenching assay
This assay was used to assess the ability of the polymers to condense the DNA. 15 A stock solution of DNA (10 g/ml) and EtBr (2.5 g/ml) was prepared in hepes buffer and incubated for 45 min. The polycations were added incrementally to each well and the plate was read on a microplate reader (BioTek EL-311). The excitation and emission wavelength were 540 and 595 nm, respectively. EtBr was used as a blank and substracted from sample readings and percentages of fluorescence were calculated.
Particle size and zeta potential measurements
The size of the polycation/DNA complexes was determined by laser light scattering (Brookhaven 90 plus; Brookhaven Instruments, NY, USA). The DNA complexes were prepared either in hepes buffer or water as explained in Materials and methods. One microgram of DNA in 250 l of hepes buffer solution was added to the appropriate amount of the polymers to result in the above-mentioned DNA/polycation ratios. The mixtures were vortexed and the measurements were carried out at room temperature 45 min after mixing. For zeta potential measurements, polymer/DNA complexes were prepared in the same manner as for particle size analysis. Samples were diluted by addition of 4 ml of pure water and contained a final concentration of 20 g/ml DNA. The system was calibrated using a -55 mV standard.
Endonuclease degradation DNA/polymer complexes containing a constant amount of DNA (10 g) were prepared as explained previously and were treated with RNase free DNAse-I (0.01 U) for 30 min at 37°C in a buffer (pH 7.9) containing 10 mM tris and 5 mM MgCl 2 . The reaction was stopped by adding 0.5 M EDTA pH 8.0. The samples were then extracted with phenol/chloroform and then precipitated with ethanol. The stability and topology of DNA were assessed by electrophoresis on an agarose gel (1%) stained with EtBr and the bands visualized using a luminometer.
Cell culture COS-7 cells (SV40-transformed African green monkey kidney) were grown in DMEM supplemented with 10% heat inactivated fetal bovine serum and antibiotics. The cells were maintained at 37°C in a 5% CO2 humidified atmosphere and subcultured by trypsinization at 5-day intervals at a seeding density of 2 × 10 4 /cm 2 . The cells were routinely tested for mycoplasmae by the Hoechst 33 258 DNA staining method and confirmed to be free of contamination.
Cytotoxicity testing
Cytotoxicity studies of polymer/DNA complexes were performed using the trypan blue dye exclusion and MTT assay based on the observation that the mitochondria in living cells can catalyze MTT molecules to a colorimetrically detectable dye. 19 Polymer/DNA complexes were prepared in cell medium at 0.25, 0.5, 1, 2, 4 and 8 w/w polymer/DNA ratios as explained previously and the results were compared with that of the polymer alone at the equivalent concentrations. Cells (3 × 10 5 ) were grown in six-well plates (40-50% confluent) and then treated with DNA/polymer complexes or polymer alone in the presence of serum (FBS 10%) for 4 h. For trypan blue assay, trypsinized cells stained with 0.4% trypan blue dye and trypan blue positive and negative cells were counted using a hemocytometer under phase contrast microscope (Nikon Instrument, NY, USA). For MTT assay, trypsinized cells were seeded in 96-well plate at 10 5 cells/well. MTT was dissolved in phosphate buffered saline (PBS) at a concentration of 5 mg/ml and filtered through 0.2 m membrane filter. Ten microliters of MTT solution was then added to each well and the cells were incubated at 37°C for 4 h. Thereafter, acid-isopropanol solution (100 l of 0.04 N HCl in isopropanol) was added to all wells and mixed thoroughly to dissolve the dark blue precipitate and incubated for 10 min at room temperature. Absorbance of samples was determined at a wavelength of 580 nm and a reference wavelength of 630 nm using a BioTek EL 311 Microplate Reader. The extent of cytotoxicity was defined as the relative reduction of the optical density (OD), which correlated to the amount of viable cells in relation to cell control (= 100%).
In vitro gene expression
The cells were seeded in a six-well culture plate at 3 × 10 5 cells/well 24 h before transfection experiments and incubated in the incubator. The complexes containing a constant amount of DNA (2 g/well) were prepared at 0.25, 0.5, 1, 2, 4 and 8 polymer/DNA weight ratios as explained previously and added to the subconfluent cells in the presence of serum (10%). After incubation at 37°C for 4 h in a 5% CO 2 incubator, the transfection medium was replaced with regular growth medium containing 10% FBS and the cells were harvested at 42 h after transfection. Transfection studies were performed in quadruplicate.
Measurement of ␤-Gal activity: After transfection experiments the cells were washed with PBS and lysed by adding 400 l of 1 × lysis buffer (Promega, Madison, WI, USA). The lysate (50 l) was mixed with ONGP (O-nitrophenyl-b-d-galactopyronoside) in 2 × assay buffer and incubated at 37°C for 30 min. The reaction was terminated by adding 500 l of 1 M Na 2 CO 3 and ␤-Gal activity was determined spectrophotometrically. Total protein was assayed by the modified Bradford method. 20 In positive control experiments, cells were transfected with plasmid alone or lipofectamine according to the manufacturer's protocol.
